Henry Hirschberg

Dr. Henry Hirschberg


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Waseem JerjesWaseem Jerjes
Waseem Jerjes
Theodossis A. TheodossiouTheodossis A. Theodossiou
Theodossis A. Theodossiou
HHHenry Hirschberg
Henry Hirschberg
AHAnders Høgset
Anders Høgset
Anette WeyergangAnette Weyergang
Anette Weyergang
Kristian BergKristian Berg
Kristian Berg
Photochemical internalisation (PCI) is a unique intervention which involves the release of endocytosed macromolecules into the cytoplasmic matrix. PCI is based on the use of photosensitizers placed in endocytic vesicles that, following light activation, lead to rupture of the endocytic vesicles and the release of the macromolecules into the cytoplasmic matrix. This technology has been shown to improve the biological activity of a number of macromolecules that do not readily penetrate the plasma membrane, including type I ribosome-inactivating proteins (RIPs), gene-encoding plasmids, adenovirus and oligonucleotides and certain chemotherapeutics, such as bleomycin. This new intervention has also been found appealing for intracellular delivery of drugs incorporated into nanocarriers and for cancer vaccination. PCI is currently being evaluated in clinical trials. Data from the first-in-human phase I clinical trial as well as an update on the development of the PCI technology towards clinical practice is presented here.

23 March 2021 in OBM Neurobiology
Verified
Journal Article
Open access
PDF file
LNLina Nguyen
Lina Nguyen
GRGabrielle Romena
Gabrielle Romena
ENEthan Nguyen
Ethan Nguyen
CTCassandra Tran
Cassandra Tran
KNKaitlyn Nguyen
Kaitlyn Nguyen
HHHenry Hirschberg
Henry Hirschberg
Following post-operative treatment, the vast majority of GBMs recur, usually within 2 cm of the tumor resection margin. Since these tumors seldom metastasize outside the CNS, improved localized therapies should prove beneficial. Drug delivery systems (DDS) that allow control over drug release by an externally applied energy, such as light, have the potential of improving the results of chemotherapy. Light-activated hydrogel DDS, implanted in the operative cavity formed by tumor resection, bypasses the blood brain barrier and allows for a precise spatio-temporal control of drug release or drug activation. Localized, on-demand release of anticancer drugs to normal brain infiltrated by tumor cells should therefore improve therapeutic efficacy and minimize systemic, drug-related side effects. Various forms of light-activated hydrogels have utilized near infrared, visible or ultraviolet wavelength irradiation. One form of hydrogel, fibrin glue (FG), composed of a combination of fibrinogen and thrombin, has several characteristics that make it well-suited for this form of sustained release drug delivery. Unlike most synthetic hydrogels, FG is a natural product and has been used clinically in surgery for decades, so its biocompatibility and lack of toxicity has been clearly proven. The light-driven drug activation technology, photochemical internalization (PCI) has been shown to enhance the intracellular efficacy of chemotherapeutic agents released from fibrin glue. A summary of the light-activated hydrogel techniques developed for the site and temporal-specific delivery of chemotherapy for the treatment of GBM will be discussed in this review.

5 February 2026 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
ACAkhil Chandekar
Akhil Chandekar
SLSophia Renee Laurel
Sophia Renee Laurel
KGKeya Gupta
Keya Gupta
TLTyler Lee
Tyler Lee
NWNicole Wakida
Nicole Wakida
HHHenry Hirschberg
Henry Hirschberg
Glioblastoma multiforme (GBM) is characterized by extensive tumor cell invasion into normal brain tissue leading to tumor recurrence despite present day treatment protocols. Photodynamic therapy (PDT) has been shown to inhibit glioma cell invasion, but the poor penetration of light in brain tissue has set limitations. Sonodynamic therapy (SDT), utilizing sensitizer activation by ultrasound (US), has been proposed as an alternative to PDT. The advantage of SDT is that US has much lower tissue attenuation compared to visible light, allowing treatment to tumor margins buried deep within the brain and non-invasively through the intact skull. This study evaluates the ability of SDT to inhibit glioma cell invasiveness in a 3D Matrigel matrix glioma cell assay. Glioma cell spheroids were embedded between 2 layers of Matrigel solution. After gelation, the embedded spheroids are incubated in a medium containing sonosensitizer for 18 h and then exposed to varying intensities and durations of US. Measurements of cell invasion distance were taken 4 days after the spheroids were embedded. SDT significantly inhibited cell invasiveness compared to untreated spheroids and spheroids treated with only US. If administered pre-implantation, SDT also inhibited subsequent cell invasion into the deposited Matrigel matrix. The effects of SDT applied repetitively at lower intensities, had a greater inhibitory effect than single shot treatment. From this experimental study using GBM tumor spheroids, the results demonstrated that SDT significantly inhibited cell invasiveness and cell adhesion and had greater inhibitive effects when administered in repetitive form.

7 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SLSophia Renee Laurel
Sophia Renee Laurel
KGKeya Gupta
Keya Gupta
JNJane Nguyen
Jane Nguyen
ACAkhil Chandekar
Akhil Chandekar
JLJustin Le
Justin Le
HHHenry Hirschberg
Henry Hirschberg
Background/Objectives: Although the use of radiation-sensitizing agents has been shown to enhance the effect of radiation on tumor cells, the blood-brain barrier (BBB) impedes these agents from reaching brain tumor sites when given systemically. Localized methods of sensitizer delivery, utilizing hydrogels, have the potential to bypass the blood-brain barrier. This study examined the ability of photochemical internalization (PCI) of hydrogel-released bleomycin to enhance the growth-inhibiting effects of radiation on multi-cell glioma spheroids in vitro; Methods: Loaded fibrin hydrogel layers were created by combining thrombin, fibrinogen, and bleomycin (BLM). Supernatants from these layers were collected, combined with photosensitizer, and added to F98 glioma spheroid cultures. Following light (PCI) and radiation treatment, at increasing dosages, spheroid growth was monitored for 14 days; Results: PCI of released BLM significantly reduced the radiation dose required to achieve equivalent efficacy compared to radiation or BLM+RT alone. Both immediate and delayed RT delivery post BLM-PCI resulted in similar degrees of growth inhibition; Conclusion: Non-degraded BLM was released from the fibrin hydrogel. PCI of BLM synergistically increased the growth-inhibiting effects of radiation treatment compared to radiation and BLM, and radiation acting as a single treatment.

30 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
SLSophia Renee Laurel
Sophia Renee Laurel
KGKeya Gupta
Keya Gupta
JNJane Nguyen
Jane Nguyen
ACAkhil Chandekar
Akhil Chandekar
JLJustin Le
Justin Le
HHHenry Hirschberg
Henry Hirschberg
Background/Objectives: Although the use of radiation-sensitizing agents has been shown to enhance the effect of radiation on tumor cells, the blood–brain barrier (BBB) impedes these agents from reaching brain tumor sites when provided systemically. Localized methods of sensitizer delivery, utilizing hydrogels, have the potential to bypass the blood–brain barrier. This study examined the ability of photochemical internalization (PCI) of hydrogel-released bleomycin to enhance the growth-inhibiting effects of radiation on multi-cell glioma spheroids in vitro. Methods: Loaded fibrin hydrogel layers were created by combining thrombin, fibrinogen, and bleomycin (BLM). Supernatants from these layers were collected, combined with photosensitizer, and added to F98 glioma spheroid cultures. Following light (PCI) and radiation treatment, at increasing dosages, spheroid growth was monitored for 14 days. Results: PCI of released BLM significantly reduced the radiation dose required to achieve equivalent efficacy compared to radiation or BLM + RT alone. Both immediate and delayed RT delivery post-BLM-PCI resulted in similar degrees of growth inhibition. Conclusions: Non-degraded BLM was released from the fibrin hydrogel. PCI of BLM synergistically increased the growth-inhibiting effects of radiation treatment compared to radiation and BLM, as well as radiation acting as a single treatment.